159 related articles for article (PubMed ID: 10089950)
1. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
Ozkan A; Yildiz I; Yüksel L; Apak H; Celkan T
Jpn J Clin Oncol; 1999 Feb; 29(2):92-5. PubMed ID: 10089950
[TBL] [Abstract][Full Text] [Related]
2. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
[TBL] [Abstract][Full Text] [Related]
3. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
5. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Stiakaki E; Savvas S; Lydaki E; Bolonaki I; Kouvidi E; Dimitriou H; Kambourakis A; Kalmanti M
Pediatr Hematol Oncol; 1999; 16(2):101-8. PubMed ID: 10100270
[TBL] [Abstract][Full Text] [Related]
6. Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin.
Berberoglu S
Pediatr Hematol Oncol; 1995; 12(5):479-83. PubMed ID: 8519633
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
Bleiberg H; Hulstaert F; Buyse M; De Keyser P
Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
[TBL] [Abstract][Full Text] [Related]
8. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
9. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron in the prevention of chemotherapy-induced acute emesis in pediatric patients.
Uysal KM; Olgun N; Sarialioğlu F
Turk J Pediatr; 1999; 41(2):207-18. PubMed ID: 10770660
[TBL] [Abstract][Full Text] [Related]
11. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
Gershanovich M; Kolygin B; Pirgach N
Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer.
Thongprasert S
Acta Oncol; 2000; 39(2):221-4. PubMed ID: 10859015
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
[TBL] [Abstract][Full Text] [Related]
14. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
15. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
[TBL] [Abstract][Full Text] [Related]
16. [Preventive efficacies of china-made tropisetron hydrochloride and Navoban on chemotherapy-induced nausea and vomiting: a randomized controlled clinical trial].
Xie M; Wu HY; Guo Y; Liu JL; Guan ZZ; Liu YL; Wang PH; Chen Q; Huang P; Yang JW
Ai Zheng; 2005 Aug; 24(8):998-1001. PubMed ID: 16086881
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
18. Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
Garbe C; Drechsler S; Fiedler H; Tilgen W; Landthaler M; Schroeder K; Kuehne KH; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):12-6. PubMed ID: 9113121
[TBL] [Abstract][Full Text] [Related]
19. Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
Oge A; Alkiş N; Oge O; Kartum A
J Chemother; 2000 Feb; 12(1):105-8. PubMed ID: 10768522
[TBL] [Abstract][Full Text] [Related]
20. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
